11 active trials 6 recruiting 1 Phase 3 5 disease areas 1 changes in 30 days
| Phase 1 | 2 | |
| Phase 1/2 | 3 | |
| Phase 2 | 1 | |
| Phase 3 | 1 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06041529 | Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With… | Essential Hypertension | Active, Not Recruiting | 2026-02-13 |
| Phase 3 | ||||
| NCT06625957 | Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require… | Parenteral Nutrition | Recruiting | 2025-01-07 |
| Phase 2 | ||||
| NCT07415551 | Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are… | Allergic Diseases | Recruiting | 2026-04-15 |
| Phase 1/2 | ||||
| NCT06616766 | A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and… | NSCLC (Non-small Cell Lung Cancer) | Recruiting | 2026-08-17 |
| NCT05523947 | Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic… | HER2-Positive Solid Tumor | Recruiting | 2026-07-16 |
| NCT06975410 | Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR… | EGFR Overexpression | Recruiting | 2026-06-10 |
| Phase 1 | ||||
| NCT06517914 | A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult… | Healthy Participants | Active, Not Recruiting | 2026-07-28 |
| NCT07584304 | Bioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects | Healthy Subjects | Not Yet Recruiting | 2026-05-13 |
| Not specified | ||||
| NCT05835518 | An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in… | Rheumatoid Arthritis | Recruiting | 2023-05-09 |
| NCT06247280 | Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation | NSCLC | Active, Not Recruiting | 2024-12-06 |
| NCT06282549 | Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with… | Essential Hypertension | Active, Not Recruiting | 2024-11-19 |
Hypertension (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Rheumatoid Arthritis (1) · Ankylosing Spondylitis (1) · Lung Cancer (1)